rss
Evid Based Nurs 9:84 doi:10.1136/ebn.9.3.84
  • Treatment

Oestrogen and progestin increased urge and stress incontinence in postmenopausal women with coronary heart disease


 
 Q In postmenopausal women with coronary heart disease, does oestrogen and progestin treatment affect the risk of stress and urge urinary incontinence (UI)?

METHODS

GraphicDesign:

secondary analysis of a randomised placebo controlled trial (Heart Estrogen/progestin Replacement Study [HERS]).

GraphicAllocation:

{concealed}.*

GraphicBlinding:

blinded {patients, investigators, and outcome assessors}.*

GraphicFollow up period:

4–48 months.

GraphicSetting:

20 clinical centres in the US.

GraphicPatients:

1228 postmenopausal women <80 years of age who had coronary heart disease, an intact uterus, and reported no episodes of UI within the past week. {Exclusion criteria included use of oral, parenteral, vaginal, or transdermal hormones within 3 months; intolerance to hormone therapy; fasting blood sugar concentration ⩾300 mg/dl; serum triglyceride concentration ⩾300 mg/dl; serum glutamic oxaloacetic transaminase >1.2 times normal; history of …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article